ibrutinib,rituximab
abbvie,janssen
[' ibru', 'leukemia', 'mantle,(-dismantle)', 'ritux', 'lymsm', 'lymphoma']
#ash22 #lymsm dreyling: triangle accrued fit (for auto) untreated mcl patients and randomized between standard chemo+auto, chemo/ibr+auto+ibrmaint, vs chemo/ibr+ibrmaint (no auto). n=870 randomized. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)